Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates

Synapse

Volumn 33, Issue 1, 1999, Pages 36-48

  Laprade, Nathalie ^a   Soghomonian, Jean Jacques ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 hydroxy dopamine; Dopamine; GABA; Glutamic acid decarboxylase; Neostriatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; GLUTAMATE DECARBOXYLASE; MESSENGER RNA; OXIDOPAMINE; PREPRODYNORPHIN; PREPROENKEPHALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; GENE EXPRESSION; IN SITU HYBRIDIZATION; NERVE LESION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; BRAIN DISEASES; CORPUS STRIATUM; DYNORPHINS; ENKEPHALINS; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; ISOENZYMES; NEURONS; OXIDOPAMINE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0033168877     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199907)33:1<36::AID-SYN4>3.0.CO;2-0     Document Type: Article

References (54)

1. Asselin M-C, Soghomonian J-J, Côté P-Y, Parent A. 1994. Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys. Neuroreport 5:2137-2140.
2. Breese GR, Baumeister A, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA. 1984. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharm Exp Ther 231:343-354.
3. Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA. 1985. Evidence that D-1 dopamine receptors contributes to the supersensitive behavioral responses induced by l-hydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J Pharm Exp Ther 235:287-295.
4. Bruno JP, Stricker EM, Zigmond MJ. 1985. Rats given dopamine-depleting brain lesions as neonates are subsensitive to dopaminergic antagonists as adults. Behav Neurosci 99:771-775.
5. Calabresi P, Mercuri N, Stanzione P, Stefani A, Bernardi G. 1987. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence from D1 receptor involvement. Neuroscience 20:757-771.
6. Calabresi P, Mercuri N, Sancesario G, Bernardi G. 1993. Electrophysiology of dopamine-denervated striatal neurons. Brain 116:433-452.
7. Cenci MA, Campbell K, Bjorklund A. 1997. Glutamic acid decarboxylase gene expression in the dopamine-denervated striatum: effects of intrastriatal fetal nigral transplants or chronic apomorphine treatment. Mol Brain Res 48:149-155.
8. Consolo S, Girotti P, Russi G, Di Chiara G. 1992. Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum. J Neurochem 59:1555-1557.
9. Cox KH, DeLeon DV, Angerer LM, Angerer RC. 1984. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101:485-502.
10. Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin AJ. 1991. Two genes encode distinct glutamate decarboxylases. Neuron 7:91-100.
11. Esclapez M, Tillakaratne NJK, Kaufman DL, Tobin AJ, Houser CR. 1994. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 14:1834-1855.
12. Gerfen CR, Young WS III. 1988. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460:161-167.
13. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR. 1990. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1429:1432-1434.
14. Gerfen CR, McGinty J, Young WS. 1991. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11:1016-1031.
15. Gonon F. 1997. Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J Neurosci 17:5972-5978.
16. Johnson BJ, Bruno JP. 1992. D1 and D2 receptor mediation of sensorimotor behavior in rats depleted of dopamine during development. Behav Brain Res 47:49-53.
17. Joyce JN, Frohna PA, Neal-Beliveau BS. 1996. Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci Behav Rev 20:453-486.
18. Kaufman DL, McGinnis JF, Krieger NR, Tobin AJ. 1986. Brain glutamate decarboxylase cloned in lambda gt-11: fusion protein produces gamma-aminobutyric acid. Science 232:1138-1140.
19. Kaufman DL, Houser CR, Tobin AJ. 1991. Two forms of the GABA synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions. J Neurochem 56:720-723.
20. Laprade N, Soghomonian J-J. 1995a. Differential regulation mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Mol Brain Res 34:65-74.
21. Laprade N, Soghomonian J-J. 1995b. Differential regulation of GAD65 and GAD67 in sub-populations of striatal neurons. Soc Neurosci Abstr 21:1428.
22. 2A receptor and its mRNA in a subpopulation of rat striatal neurons. J Neurosci 16:3727-3736.
23. Laprade N, Soghomonian J-J. 1997. Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons. Mol Brain Res 48:333-345.
24. Luthman J, Friedemann M, Bickford P, Olson L, Hoffer BJ, Gerhardt GA. 1993. In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment. Neuroscience 52:677-687.
25. Marchi M, Sanguineti P, Raiteri. 1990. Muscarinic receptors mediate direct inhibition of GABA release from rat striatal nerve terminals. Neurosci Lett 116:347-351.
26. Martin DL, Martin SB, Wu SJ, Espina N. 1991. Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain. J Neurosci 11:2725-2731.
27. Mercugliano M, Soghomonian J-J, Qin Y, Nguyen HQ, Feldblum S, Erlander MG, Tobin AJ, Chesselet M-F. 1992. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat. J Comp Neurol 318:245-254.
28. Molina-Holgado E, Dewar KM, Grondin L, Van Gelder NM, Reader TA. 1993. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and raphe nuclei. J Neurosci Res 35:1-10.
29. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. Orlando, FL: Academic Press.
30. Pedneault S, Soghomonian J-J. 1994. Glutamate decarboxylase (GAD65) mRNA levels in the striatum and pallidum of parkinsonian primates. Mol Brain Res 25:351-354.
31. Pinal CS, Cortessis V, Tobin AJ. 1997. Multiple elements regulate GAD65 transcription. Dev Neurosci 19:465-475.
32. Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P. 1991. GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 10:1275-1284.
33. Robertson RG, Graham WC, Sambrook MA, Crossman AR. 1991. Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of γ-aminobutyric acid in the lateral segment of the globus pallidus. Brain Res 563:278-280.
34. Salin P, Mercugliano M, Chesselet M-F. 1990. Differential effects of chronic haloperidol and clozapine on preprosomatostatin mRNA in the striatum, nucleus accumbens and frontal cortex of the rat. Cell Mol Neurobiol 10:127-144.
35. Sandstrom MI, Sarter M, Bruno JP. 1996. Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates. Dev Brain Res 23:148-158.
36. Schallert T, Petrie BF, Wishaw IQ. 1989. Neonatal dopamine depletion: spared and unspared sensorimotor and attentional disorders and effects under depletion in adulthood. Psychobiology 17:386-396.
37. Segovia J, Tossman U, Herrera-Marschitz M, Garcia-Munoz M, Ungerstedt U. 1986. Gamma-aminobutyric acid release in the globus pallidus in vivo after 6-hydroxydopamine lesion in the substantia nigra of the rat. Neurosci Lett 70:364-368.
38. Sivam SP, Breese GR, Krause JE, Napier TC, Mueller RA, Hong J-S. 1987. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J Neurochem 49:1623-1633.
39. Smolders I., Bogaert L, Ebinger G, Michotte Y. 1997. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis. J Neurochem 68:1942-1948.
40. Soghomonian J-J. 1993. Effects of neonatal 6-hydroxydopamine injections on glutamate decarboxylase, preproenkephalin and dopamine D2 receptor mRNAs in the adult rat striatum. Brain Res 621:249-259.
41. Soghomonian J-J. 1994. Differential regulation of glutamate decarboxylase and preproenkephalin mRNA levels in the rat striatum. Brain Res 640:146-154.
42. Soghomonian J-J, Laprade N. 1997. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of parkinsonian monkeys. Synapse 27:122-132.
43. Soghomonian J-J, Gonzales C, Chesselet M-F. 1992. Messenger RNAs encoding glutamate-decarboxylase are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Brain Res 576:68-79.
44. Soghomonian J-J, Pedneault S, Audet G, Parent A. 1994. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates. J Neurosci 14:6256-6265.
45. Steiner H, Gerfen CR. 1995. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J Comp Neurol 353:200-212.
46. Surmeier DJ, Bargas J, Hemmings HJ, Nairn AC, Greengard P. 1995. Modulation of calcium currents by a D1 dopaminergic protein kinase phosphatase cascade in rat neostriatal neurons. Neuron 14:385-397.
47. Szabo G, Katarova Z, Kortvely E, Gennspan RJ, Urban Z. 1996. Structure and the promoter region of the mouse gene encoding the 67-kD form of glutamic acid decarboxylase DNA. Cell Biol 15:1081-1091.
48. Tossman U, Segovia J, Ungerstedt U. 1986. Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis. Acta Physiol Scand 127:547-551.
49. Tremblay M, Rouillard C, Lévesque D. 1997. Dopamine D3 receptor antisense reduces neuropeptide mRNA levels in rat nucleus accumbens. Neuroreport 8:3901-3905.
50. Weihmuller FB, Bruno JP. 1989. Drinking behavior and motor function in rat pups depleted of brain dopamine during development. Dev Psychobiol 22:101-113.
51. Whishaw IQ, Funk DR, Hawryluk SJ, Karbashewski ED. 1987. Absence of sparing of spatial navigation, skilled forelimb and tongue use and limb posture in the rat after neonatal dopamine depletion. Physiol Behav 40:247-253.
52. Yan Z, Song WJ, Surmeier J. 1997. D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J Neurophysiol 77:1003-1015.
53. Yoshikawa K, Williams C, Sabol SL. 1984. Rat brain preproenkephalin mRNA. J Biol Chem 259:14301-14308.
54. Young WS, Bonner TI, Brann M. 1986. Mesencephalic neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83:9827-9831.